Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The onset of acute oxcarbazepine toxicity related to prescription of clarithromycin in a child with refractory epilepsy.

× No keyword cloud information.

11 in total

Review 1. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs.

Authors: Wolfgang Löscher; Heidrun Potschka
Journal: J Pharmacol Exp Ther Date: 2002-04 Impact factor: 4.030

Review 2. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.

Authors: Wolfgang Löscher; Heidrun Potschka
Journal: Prog Neurobiol Date: 2005-05 Impact factor: 11.685

3. Quantitative in vivo microdialysis study on the influence of multidrug transporters on the blood-brain barrier passage of oxcarbazepine: concomitant use of hippocampal monoamines as pharmacodynamic markers for the anticonvulsant activity.

Authors: Ralph Clinckers; Ilse Smolders; Alfred Meurs; Guy Ebinger; Yvette Michotte
Journal: J Pharmacol Exp Ther Date: 2005-04-28 Impact factor: 4.030

4. Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy.

Authors: F Pisani; A Fazio; G Oteri; C Artesi; B Xiao; E Perucca; R Di Perri
Journal: Acta Neurol Scand Date: 1994-08 Impact factor: 3.209

5. Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus.

Authors: Jens P Bankstahl; Wolfgang Löscher
Journal: Epilepsy Res Date: 2008-08-29 Impact factor: 3.045

6. An oxcarbazepine-related fatality with an overview of 26 oxcarbazepine postmortem cases.

Authors: Kristian Linnet; Anni Steentoft; Kirsten W Simonsen; Anne Sabers; Steen Holger Hansen
Journal: Forensic Sci Int Date: 2007-11-26 Impact factor: 2.395

7. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.

Authors: P J McKee; J Blacklaw; G Forrest; R A Gillham; S M Walker; D Connelly; M J Brodie
Journal: Br J Clin Pharmacol Date: 1994-01 Impact factor: 4.335

8. Efficiency and safety of oxcarbazepine in mood disorders: a naturalistic study exploring the interest of plasma dosages.

Authors: David Misdrahi; Marie Tournier; Tiphaine Droulout; Adeline Grolleau; Karine Titier; Mathieu Molimard; Helene Verdoux
Journal: Eur Psychiatry Date: 2008-08-27 Impact factor: 5.361

Review 9. Clinical pharmacokinetics of oxcarbazepine.

Authors: Theodor W May; Elisabeth Korn-Merker; Bernhard Rambeck
Journal: Clin Pharmacokinet Date: 2003 Impact factor: 6.447

10. Absence of interaction between oxcarbazepine and erythromycin.

Authors: T Keränen; J Jolkkonen; P K Jensen; G P Menge; P Andersson
Journal: Acta Neurol Scand Date: 1992-08 Impact factor: 3.209

3 in total

1. Interactions Between Antiepileptic and Antibiotic Drugs: A Systematic Review and Meta-Analysis with Dosing Implications.

Authors: Carla Carnovale; Marco Pozzi; Faizan Mazhar; Giulia Mosini; Marta Gentili; Gabriëlla G A M Peeters; Emilio Clementi; Sonia Radice
Journal: Clin Pharmacokinet Date: 2019-07 Impact factor: 6.447

2. The safety and tolerability of newer antiepileptic drugs in children and adolescents.

Authors: Saima Kayani; Deepa Sirsi
Journal: J Cent Nerv Syst Dis Date: 2012-03-08

3. Expression of Multidrug Resistance Genes in Peripheral Blood of Patients with Refractory Epilepsy and the Reverse Effect of Oxcarbazepine on Its Expression.

Authors: Jinming Ji; Gang Li; Yunxia Ma; Shuangshuang Pan; Rongrong Yuan
Journal: Iran J Public Health Date: 2018-01 Impact factor: 1.429

3 in total